Spero Therapeutics, Inc. (SPRO)
2.79
+0.03
(+1.09%)
USD |
NASDAQ |
May 15, 16:00
2.795
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Market Cap : 161.55M for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| SELLAS Life Sciences Group, Inc. | 1.317B |
| Lantern Pharma, Inc. | 35.34M |
| ACADIA Pharmaceuticals, Inc. | 3.664B |
| Alnylam Pharmaceuticals, Inc. | 38.32B |
| Amgen, Inc. | 176.21B |
Market Cap Related Metrics
| PE Ratio | 11.45 |
| PS Ratio | 2.916 |
| Price to Book Value | 3.052 |
| Price to Free Cash Flow | 22.05 |
| Price | 2.79 |
| Earnings Yield | 8.73% |
| Operating PE Ratio | 20.59 |
| Normalized PE Ratio | 11.07 |